benzylguanidine has been researched along with Idiopathic Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirayama, M; Mizutani, Y; Nakamura, T; Okada, A; Sobue, G; Suzuki, J; Watanabe, H | 1 |
| Hironishi, M; Kajimoto, Y; Kondo, T; Miwa, H; Okawa-Izawa, M | 1 |
2 other study(ies) available for benzylguanidine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Hyposmia and cardiovascular dysautonomia correlatively appear in early-stage Parkinson's disease.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Cardiovascular Diseases; Discrimination, Psychological; Female; Guanidines; Humans; Iodine Isotopes; Male; Middle Aged; Odorants; Olfaction Disorders; Parkinson Disease; Smell; Valsalva Maneuver | 2014 |
Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease.
Topics: Aged; Aged, 80 and over; Female; Guanidines; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Statistics, Nonparametric; Substantia Nigra; Ultrasonography, Doppler, Transcranial | 2009 |